Signal transduction for PDGF-induced chemotaxis of vascular smooth muscle cells

Annals of the New York Academy of Sciences

Volumn 811, Issue , 1997, Pages 130-133

  Shimokado, Kentaro ^a   Higaki, Masahide ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE;

CELL MIGRATION; CHEMOTAXIS; CONFERENCE PAPER; CYTOSKELETON; ENZYME ACTIVITY; HUMAN; NONHUMAN; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0030742259     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb51995.x     Document Type: Conference Paper

References (14)

1. ROSS, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809.
2. JACKSON, C. L., E. W. RAINES, R. ROSS & M. A. REIDY. 1993. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler. Thromb. 13: 1218-1226.
3. MATSUI, T., J. H. PIERCE, T. P. FLEMING, J. S. GREENBERGER, W. J. LAROCHELLE, M. RUGGIERO & S. A. AARONSON. 1989. Independent expression of human α or β platelet-derived growth factor receptor cDNAs in a native hematopoietic cell leads to functional coupling with mitogenic and chemotactic signaling pathways. Proc. Natl. Acad. Sci. USA 86: 8314-8318.
4. MULLINS, D. E., F. HAMUD, R. REIM & H. R. DAVIS. 1994. Inhibition of PDGF receptor binding and PDGF-stimulated biological activity in vitro and of intimai lesion formation in vivo by 2-bromomethyl-5-chlorobenzene sulfonylphthalimide. Arterioscler. Thromb. 14: 1047-1055.
5. FANTL, W. J., D. E. JOHNSON & L. T. WILLIAMS. 1993. Signalling by receptor tyrosine kinases. Annu. Rev. Biochem. 62: 453-481.
6. CLAESSON-WELSH, L. 1994. Platelet-derived growth factor receptor signals. J. Biol. Chem. 269: 32023-32026.
7. KUNDRA, V., J. A. ESCOBEDO, A. KAZLAUSKAS, H. K. KIM, S. G. RHEE, L. T. WILLIAMS & B. R. ZETTER. 1994. Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature 367: 474-476.
8. WENNSTROM, S., A. SIEGBAHN, K. YOKOTE, A-K. ARVIDSSON, C-H. HELDIN, S. MORI & L. CLAESSON-WELSH. 1994. Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphatidylinositol 3′ kinase. Oncogene 9: 651-660.
9. HIGAKI, M., H. SAKAUE, W. OGAWA, M. KASUGA & K. SHIMOKADO. 1996. Phosphatidylinositol 3-kinase-independent signal transduction pathway for PDGF-induced chemotaxis. J. Biol. Chem. 271: 29342-29346.
10. YOKOTE, K., S. MORI, A. SIEGBAHN, L. RONNSTRAND, C. WERNSTEDT, C-H. HELDIN & L. CLAESSON-WELSH. 1996. Structural determination in the platelet-derived growth factor α-receptor implicated in modulation of chemotaxis. J. Biol. Chem. 271: 5101-5111.
11. KOYAMA, N., N. MORISAKI, Y. SAITO & S. YOSHIDA. 1992. Regulatory effect of platelet-derived growth factor-AA homodimer on migration of vascular smooth muscle cells. J. Biol. Chem. 267: 22806-228122.
12. ABEDI, H., K. E. DAWES & I. ZACHARY. 1995. Differential effects of platelet-derived growth factor BB on p125 focal adhesion kinase and paxillin tyrosine phosphorylation and on cell migration in rabbit aortic vascular smooth muscle cells and Swiss 3T3 fibroblasts. J. Biol. Chem. 270: 11367-11376.
13. RIDLEY, A. J. & A. HALL. 1992. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70: 389-399.
14. SHIMOKADO, K., T. YOKOTA, K. UMEZAWA, T. SASAGURI & J. OGATA. 1994. Protein tyrosine kinase inhibitors inhibit chemotaxis of smooth muscle cells. Arterioscler. Thromb. 14: 973-981.